These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15478579)

  • 1. Current topics in breast cancer for oncology nurses.
    ONS News; 2004; 19(9 Suppl):37-8. PubMed ID: 15478579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Should chemotherapy or endocrine therapy be used as first choice in patients with advanced breast cancer? A status article based on the Cochrane analysis "Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer"].
    Ejlertsen B; Mouridsen H
    Ugeskr Laeger; 2004 Jun; 166(25):2434-6. PubMed ID: 15283108
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on extended adjuvant therapy options in breast cancer.
    ONS News; 2004; 19(9 Suppl):51-2. PubMed ID: 15478586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
    Baumann CK; Castiglione-Gertsch M
    Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case studies in breast and colorectal cancer for the oncology nurse.
    ONS News; 2004; 19(9 Suppl):47-8. PubMed ID: 15478584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment guideline for breast cancer and SERM-treatment].
    Iwase H; Yamamoto Y; Kawasoe T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():636-40. PubMed ID: 18159717
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G
    Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on endocrine aspects of breast cancer: report from the 23rd San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 6-9 December 2000.
    Johnston SR
    Breast Cancer Res; 2001; 3(3):180-2. PubMed ID: 11305952
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs).
    Schiff R; Chamness GC; Brown PH
    Breast Cancer Res; 2003; 5(5):228-31. PubMed ID: 12927029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.
    Yamamoto Y; Masuda N; Ohtake T; Yamashita H; Saji S; Kimijima I; Kasahara Y; Ishikawa T; Sawaki M; Hozumi Y; Iwase H
    Breast Cancer; 2010 Oct; 17(4):254-60. PubMed ID: 19685269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New advances in chemotherapeutic and supportive care agents for the management of breast cancer patients.
    ONS News; 2004; 19(9 Suppl):23-6. PubMed ID: 15478573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
    Gamucci T
    Suppl Tumori; 2004; 3(4):S16. PubMed ID: 15206201
    [No Abstract]   [Full Text] [Related]  

  • 13. [The ATAC study on adjuvants in breast cancer].
    Bravi S
    Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
    Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF
    Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine therapy alone vs. chemotherapy plus endocrine therapies for the treatment of elderly patients with endocrine-responsive and node positive breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology).
    Inal A; Akman T; Yaman S; Demir Ozturk S; Geredeli C; Bilici M; Inanc M; Harputoglu H; Demirci U; Balakan O; Yesil Cinkir H; Alici S; Uysal Sonmez O; Goksel G; Gokoz Dogu G; Umit Unal O; Tamozlu T; Buyukberber S; Melih Boruban C; Isikdogan A
    J BUON; 2013; 18(1):64-9. PubMed ID: 23613390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2.
    Prat A; Baselga J
    Nat Clin Pract Oncol; 2008 Sep; 5(9):531-42. PubMed ID: 18607391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced breast cancer: recent developments in hormonal therapy.
    Cloutier AO
    Semin Oncol Nurs; 2000 Aug; 16(3):206-13. PubMed ID: 10967793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of endocrine therapy for the treatment and prevention of breast cancer.
    Gradishar WJ; Jordan VC
    Cancer Chemother Biol Response Modif; 2002; 20():227-38. PubMed ID: 12703207
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovarian ablation as a treatment for breast cancer.
    Sainsbury R
    Surg Oncol; 2003 Dec; 12(4):241-50. PubMed ID: 14998564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer: overview & updates.
    Downs-Holmes C; Silverman P
    Nurse Pract; 2011 Dec; 36(12):20-6; quiz 7. PubMed ID: 22089837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.